MICHAEL DULAY: Open Payments
NPI 1528494317 · CASTLETON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 105 payments from 12 companies in 2025. Trend: 2023 $2,023 · 2024 $1,759 · 2025 $1,647
Food & beverage: $1,637Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $484 |
| Novartis Pharmaceuticals Corporation | 24 | $294 |
| Galderma Laboratories, L.P. | 11 | $224 |
| Janssen Biotech, Inc. | 11 | $222 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $118 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| UCB, Inc. | 2 | $62 |
| Arcutis Biotherapeutics, Inc. | 3 | $52 |
| Lilly USA, LLC | 2 | $35 |
| Organon LLC | 2 | $30 |
Products named: SKYRIZI, COSENTYX, NEMLUVIO, TREMFYA, ILUMYA, Bimzelx, DUPIXENT, Zoryve.
Industry payments across NY — which companies pay providers there.
